Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma
|
Author:
|
Heitmann, Jonas S.; Walz, Juliane S.; Pfluegler, Martin; Kauer, Joseph; Schlenk, Richard F.; Jung, Gundram; Salih, Helmut R.
|
|
Tübinger Autor(en):
|
|
|
Published in:
|
Bmj Open
(2020-08), Bd.
10,
H.
10
|
|
Verlagsangabe:
|
Bmj Publishing Group
|
|
Language:
|
English
|
|
Full text:
|
http://dx.doi.org/10.1136/bmjopen-2020-039639
|
|
ISSN:
|
2044-6055
|
|
DDC Classifikation:
|
610 - Medicine and health
|
|
Dokumentart:
|
Article
|
|
Show full item record
|
